Epigenetic Programmers Targeted During Developmental Reprogramming
表观遗传程序员是发育重编程过程中的目标
基本信息
- 批准号:8584981
- 负责人:
- 金额:$ 55.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-01 至 2017-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdultBackBindingBiochemicalCardiovascular DiseasesCell Culture TechniquesCellsChIP-seqCodeCoenzyme AComplementComplexComputer SimulationDNADevelopmentDiabetes MellitusDiseaseElderlyEndocrine DisruptorsEpigenetic ProcessExposure toGene ExpressionGene TargetingGenesGeneticGenomicsGoalsImageImage AnalysisKnowledgeLifeLiverMalignant NeoplasmsMass Spectrum AnalysisMeasurementMessenger RNAMetabolicMetabolic DiseasesMethodsModelingNeonatalNuclear Hormone ReceptorsNuclear TranslocationObesityPI3K/AKTPeroxisome Proliferator-Activated ReceptorsPhospho-Specific AntibodiesPhosphorylationPhosphorylation SitePhosphotransferasesPhysiologicalPost-Translational Protein ProcessingPredispositionProcessRXRReaderReagentRecruitment ActivityRiskSignal PathwaySignal TransductionSiteTechnologyTertiary Protein StructureTestingTimeLineTissuesVisualWritingbasechromatin modificationchromatin remodelingcritical periodenvironmental stressorepigenomeepigenomicsexperienceexposed human populationhistone acetyltransferasehistone methyltransferaseinnovationliver metabolismnon-genomicnovelobesogenprogramspromoterpublic health relevanceresponsetooltranscriptome sequencing
项目摘要
DESCRIPTION (provided by applicant): Exposure of cells or tissues to environmental stressors during critical periods of development can permanently reprogram normal physiological responses to increase susceptibility to disease later in life, a process termed developmental reprogramming. Developmental reprogramming is thought to occur via disruption of the epigenome, and is now appreciated to increase risk in adulthood for metabolic diseases, including obesity, diabetes, cardiovascular disease, and cancer. We were the first to identify non-genomic (or more accurately pre-genomic) signaling as a direct mechanism for endocrine disrupting chemicals (EDCs) to disrupt the epigenetic machinery and induce developmental reprogramming. Activation of kinases in pre-genomic signaling pathways that phosphorylate readers, writers and erasers is extremely attractive as a central mechanism for environmental stressors to engage the cell's epigenetic machinery. However, tremendous knowledge gaps remain in our understanding of how the epigenomic machinery is disrupted by pre-genomic signaling during developmental reprogramming. We do not know: 1) Which kinases/pre-genomic signaling pathways beyond PI3K/AKT are activated by "obesogens" in the liver (or other tissues); 2) Which epigenomic programmers are targeted by these kinases or how phosphorylation (or other PTMs) modifies their activity (up or down); nor 3) Which specific epigenetic "marks" placed on reprogrammed genes are altered to change gene expression and increase susceptibility to obesity (or other diseases) in adulthood. The goal of this application i to fill these knowledge gaps with a detailed mechanistic understanding of how EDCs utilize pre-genomic signaling to disrupt the epigenome, and to better understand how this developmental reprogramming alters metabolic "set-points" in the liver to promote obesity.
描述(由申请人提供):在发育的关键时期,细胞或组织暴露于环境压力源可以永久地重新编程正常的生理反应,以增加生命后期对疾病的易感性,这一过程称为发育重编程。发育重编程被认为是通过表观基因组的破坏而发生的,现在人们认为它会增加成年后患代谢疾病的风险,包括肥胖、糖尿病、心血管疾病和癌症。我们是第一个发现非基因组(或更准确地说是前基因组)信号传导作为内分泌干扰化学物质(EDC)破坏表观遗传机制并诱导发育重编程的直接机制的人。激活前基因组信号通路中的激酶,使读取器、写入器和擦除器磷酸化,作为环境压力源参与细胞表观遗传机制的核心机制,极具吸引力。然而,我们对发育重编程过程中表观基因组机制如何被前基因组信号破坏的理解仍然存在巨大的知识差距。我们不知道: 1) PI3K/AKT 之外的哪些激酶/前基因组信号通路被肝脏(或其他组织)中的“致肥胖物质”激活; 2) 这些激酶针对哪些表观基因组程序员,或者磷酸化(或其他 PTM)如何改变其活性(上调或下调); 3) 重编程基因上的哪些特定表观遗传“标记”被改变以改变基因表达并增加成年后对肥胖(或其他疾病)的易感性。该应用程序的目标是通过对 EDC 如何利用前基因组信号传导破坏表观基因组的详细机制了解来填补这些知识空白,并更好地了解这种发育重编程如何改变肝脏中的代谢“设定点”以促进肥胖。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK T. BEDFORD其他文献
MARK T. BEDFORD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK T. BEDFORD', 18)}}的其他基金
Mechanisms of action and therapeutic targeting of the CARM1-NFIB axis in small cell lung cancer
CARM1-NFIB 轴在小细胞肺癌中的作用机制和治疗靶向
- 批准号:
10657854 - 财政年份:2023
- 资助金额:
$ 55.06万 - 项目类别:
MD Anderson Science Park Summer Program in Cancer Research SPCR
MD 安德森科学园癌症研究 SPCR 暑期项目
- 批准号:
10472591 - 财政年份:2014
- 资助金额:
$ 55.06万 - 项目类别:
MD Anderson Science Park Summer Program in Cancer Research SPCR
MD 安德森科学园癌症研究 SPCR 暑期项目
- 批准号:
10685275 - 财政年份:2014
- 资助金额:
$ 55.06万 - 项目类别:
Epigenetic Programmers Targeted During Developmental Reprogramming
表观遗传程序员是发育重编程过程中的目标
- 批准号:
9068106 - 财政年份:2013
- 资助金额:
$ 55.06万 - 项目类别:
Epigenetic Programmers Targeted During Developmental Reprogramming
表观遗传程序员是发育重编程过程中的目标
- 批准号:
8726398 - 财政年份:2013
- 资助金额:
$ 55.06万 - 项目类别:
Epigenetic Programmers Targeted During Developmental Reprogramming
表观遗传程序员是发育重编程过程中的目标
- 批准号:
9412709 - 财政年份:2013
- 资助金额:
$ 55.06万 - 项目类别:
Identify small molecule inhibitors of methyl-dependent protein-protein interactio
鉴定甲基依赖性蛋白质-蛋白质相互作用的小分子抑制剂
- 批准号:
8011493 - 财政年份:2010
- 资助金额:
$ 55.06万 - 项目类别:
Identify small molecule inhibitors of methyl-dependent protein-protein interactio
鉴定甲基依赖性蛋白质-蛋白质相互作用的小分子抑制剂
- 批准号:
8089366 - 财政年份:2010
- 资助金额:
$ 55.06万 - 项目类别:
Applying peptide and protein domain microarrays to epigenetic research
将肽和蛋白质域微阵列应用于表观遗传学研究
- 批准号:
7879014 - 财政年份:2009
- 资助金额:
$ 55.06万 - 项目类别:
Applying peptide and protein domain microarrays to epigenetic research
将肽和蛋白质域微阵列应用于表观遗传学研究
- 批准号:
7688691 - 财政年份:2008
- 资助金额:
$ 55.06万 - 项目类别:
相似国自然基金
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
- 批准号:82300208
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
- 批准号:82372499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Alcohol use, physical activity, and neurophysiological indicators of behavioral adaptability
饮酒、体力活动和行为适应性的神经生理学指标
- 批准号:
10609697 - 财政年份:2023
- 资助金额:
$ 55.06万 - 项目类别:
Novel biomarkers and pathways of persistent endometriosis-associated pain across the life course
整个生命过程中持续性子宫内膜异位症相关疼痛的新生物标志物和途径
- 批准号:
10611090 - 财政年份:2023
- 资助金额:
$ 55.06万 - 项目类别:
Identifying EEG Markers of Altered Interoceptive Processing in Chronic Pain
识别慢性疼痛中内感受处理改变的脑电图标记
- 批准号:
10606187 - 财政年份:2023
- 资助金额:
$ 55.06万 - 项目类别:
Racial and Socioeconomic Differences in Chronic Low Back Pain
慢性腰痛的种族和社会经济差异
- 批准号:
10656046 - 财政年份:2023
- 资助金额:
$ 55.06万 - 项目类别:
Development of mHealth-Supported Skills Training for Alcohol and Related Suicidality (mSTARS): Emotion Regulation Skills Training to Enhance Acute Psychiatric Care and Recovery
开发移动医疗支持的酒精和相关自杀技能培训 (mSTARS):情绪调节技能培训,以加强急性精神科护理和康复
- 批准号:
10721452 - 财政年份:2023
- 资助金额:
$ 55.06万 - 项目类别: